THE POSSIBILITIES OF COMPLEX VISUAL DIAGNOSTICS OF LIVER PATHOLOGY IN PATIENTS WITH DIFFUSE LIVER DISEASES ASSOCIATED WITH COVID-19.
DOI:
https://doi.org/10.31618/ESSA.2782-1994.2021.4.75.173Keywords:
diffuse liver disease, diagnostics, COVID-19, arterial spin labeling, magnetic resonance imaging.Abstract
The research shows the possibilities of visual diagnostics of liver pathology in patients with various diffuse liver diseases and COVID-19. The analysis is based on the results of examination of patients, who got hospital treatment in Clinical Hospital №1 of Smolensk from September to November 2021. The research shows the efficiency of ultrasound diagnosis as the first step of examination.
Using Magnetic Resonance Imaging (MRI) allowed to study the symptoms of liver pathology more deeply. In order to improve the exact specific diagnosis of liver pathology in patients with diffuse liver diseases and COVID-19, arterial spin labeling technique is recommended to use. The research shows the efficiency of complex using of diagnostic methods in patients with diffuse liver diseases and SARS-CoV-2 infection
References
Vernon G. Baranova A. Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults.Aliment Pharmacol Ther. 2011; 34: 274-285
Martin Blachier, Henri Leleu, Markus PeckRadosavljevic, Dominique-Charles Valla and Françoise Roudot-Thoraval The Burden of liver disease in Europe. A review of available epidemiological data. 2013
Ascha M.S. Hanouneh I.A. Lopez R. Tamimi T.A. Feldstein A.F. Zein N.N. The incidence and risk factor of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51: 1972-1978
Cadranel J. Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol. Clin. Biol. 2002; 26: 823–824. PMID: 12434092
Hope TA, Ohliger MA, Qayyum A: MR imaging of diffuse liver disease: from technique to diagnosis. Radiol Clin North Am. 2014, 52:709–724. 10.1016/j.rcl.2014.02.016
Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY). 2017 Feb;42(2):490-501. doi: 10.1007/s00261-016-0913-6. PMID: 27678393
Ho ML. Arterial spin labeling: Clinical applications. J Neuroradiol. 2018 Sep;45(5):276-289. doi: 10.1016/j.neurad.2018.06.003. Epub 2018 Jul 27. PMID: 30016705
Morozova T.G., Simakina E.N., Gel't T.D. Osnovnye kriterii ASL-perfuzii pecheni pri virusnyh gepatitah. Medicinskaja vizualizacija. 2021;25(1):73-79 [Morozova T.G., Simakina E.N., Gelt T.D. The main criteria for ASL-perfusion of the liver in viral hepatitis. Medical Visualization. 2021;25(1):73-79. (In Russ.)].
https://doi.org/10.24835/1607-0763-932
Trufanov G.E. , Fokin V.A. , Asaturjan E.G. , Efimcev A.Ju., Shmedyk N.Ju., Mashhenko I.A., Chegina D.S. , Aldatov R.H. Metodika arterial'nogo spinovogo markirovanija: klinicheskoe primenenie. REJR 2019; 9(4):129-147. [Trufanov G.E., Fokin V.A., Asaturyan E.G., Efimtsev A.Yu., Shmedyk N.Yu., Mashchenko I.A., Chegina D.S., Aldatov R.Kh. Arterial spin labeling: slinical applications. REJR 2019; 9(4):129-147. (In Russ.)]DOI:10.21569/2222-7415-2019-9-4-129-147
Lee I.C., Huo T.I., Huang Y.H. Gastrointestinal and Liver Manifestations in Patients with COVID-19. J. Chin. Med. Assoc. 2020; 10.1097/JCMA.0000000000000319. https://doi.org/10.1097/JCMA.0000000000000319
Vinokurov A.S., Nikiforova M.V., Oganesjan A.A., Vinokurova O.O., Judin A.L., Jumatova E.A. COVID-19. Porazhenie pecheni – osobennosti vizualizacii i vozmozhnye prichiny. Medicinskaja vizualizacija. 2020; 24 (3): 26–36. [Vinokurov A.S., Nikiforova M.V., Oganesyan A.A., Vinokurova O.O., Yudin A.L., Yumatova E.A. COVID-19. Liver damage – visualization features and possible causes. Medical Visualization. 2020; 24 (3): 26–36. (In Russ.)] https://doi.org/10.24835/1607-0763-2020-3-26-36
Gambino R. Cassader M. Pagano G. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity. Annals of Medicine. 2011; 43 (G): 617-649
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
